FDA posts warning letter sent to Abiomed over Impella marketing

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=-zJN6U2J7Cs

The FDA said Abiomed (NASDAQ:ABMD) is marketing the Impella Recover LP 2.5 Percutaneous Cardiac Support System device in the United States without the requir...

ABMD, business, comtex, income, investment, market, news, shares, smartrend, stocks, trade, update
#############################